Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Bacterial Infections and Mycoses

  Free Subscription


24.10.2022

5 Am J Trop Med Hyg
13 Antimicrob Agents Chemother
1 BMC Neurol
16 Clin Infect Dis
6 Curr Microbiol
1 Eur J Clin Microbiol Infect Dis
2 J Bacteriol
1 J Biol Chem
6 J Clin Microbiol
1 N Engl J Med
5 PLoS Negl Trop Dis
9 PLoS One
3 PLoS Pathog


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Trop Med Hyg

  1. BURHAN E, Karyana M, Karuniawati A, Kusmiati T, et al
    Characteristics of Drug-sensitive and Drug-resistant Tuberculosis Cases among Adults at Tuberculosis Referral Hospitals in Indonesia.
    Am J Trop Med Hyg. 2022 Oct 17. pii: tpmd220142. doi: 10.4269/ajtmh.22-0142.
    PubMed         Abstract available

  2. CHAE SR, Lukupulo H, Kim S, Walker T, et al
    An Assessment of Household Knowledge and Practices during a Cholera Epidemic- Dar es Salaam, Tanzania, 2016.
    Am J Trop Med Hyg. 2022;107:766-772.
    PubMed         Abstract available

  3. JAMIR I, Ketan P, Anguraj S, Jahan L, et al
    Case Report: Bloodstream Infection with Toxigenic Corynebacterium diphtheriae and Gram-Negative Sepsis in a Child with Burns.
    Am J Trop Med Hyg. 2022 Aug 29. pii: tpmd211233. doi: 10.4269/ajtmh.21-1233.
    PubMed         Abstract available

  4. BESTUL N, Padilla R, Montano T, Marquez A, et al
    Knowledge, Attitudes, and Practices on Rocky Mountain Spotted Fever among Physicians in a Highly Endemic Region-Mexicali, Mexico.
    Am J Trop Med Hyg. 2022;107:773-779.
    PubMed         Abstract available

  5. LI J, Xiong T, Yue Y, Choonara I, et al
    Secondary Effects from Mass Azithromycin Administration: A Systematic Review and Meta-analysis.
    Am J Trop Med Hyg. 2022;107:904-911.
    PubMed         Abstract available


    Antimicrob Agents Chemother

  6. MON KKZ, Si Z, Chan-Park MB, Kenney LJ, et al
    Polyimidazolium Protects against an Invasive Clinical Isolate of Salmonella Typhimurium.
    Antimicrob Agents Chemother. 2022;66:e0059722.
    PubMed         Abstract available

  7. LUTERBACH CL, Qiu H, Hanafin PO, Sharma R, et al
    A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.
    Antimicrob Agents Chemother. 2022 Sep 20:e0059122. doi: 10.1128/aac.00591.
    PubMed         Abstract available

  8. PINCUS NB, Rosas-Lemus M, Gatesy SWM, Bertucci HK, et al
    Functional and Structural Characterization of OXA-935, a Novel OXA-10-Family beta-Lactamase from Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2022;66:e0098522.
    PubMed         Abstract available

  9. FINDLAY J, Rens C, Poirel L, Nordmann P, et al
    In Vitro Mechanisms of Resistance Development to Imipenem-Relebactam in KPC-Producing Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2022;66:e0091822.
    PubMed         Abstract available

  10. AL-ZUBAIDI A, Cheung CY, Cook GM, Taiaroa G, et al
    RNase HI Depletion Strongly Potentiates Cell Killing by Rifampicin in Mycobacteria.
    Antimicrob Agents Chemother. 2022;66:e0209121.
    PubMed         Abstract available

  11. PHIPPS AJ, Bergmann JN, Albrecht MT, Singh VK, et al
    Model for Evaluating Antimicrobial Therapy To Prevent Life-Threatening Bacterial Infections following Exposure to a Medically Significant Radiation Dose.
    Antimicrob Agents Chemother. 2022;66:e0054622.
    PubMed         Abstract available

  12. PETRAITIS V, Petraitiene R, Kavaliauskas P, Naing E, et al
    Efficacy of Cefiderocol in Experimental Stenotrophomonas maltophilia Pneumonia in Persistently Neutropenic Rabbits.
    Antimicrob Agents Chemother. 2022;66:e0061822.
    PubMed         Abstract available

  13. KIM SR, Jang M, Kim SY, Kim DH, et al
    Outcomes of Short-Term Tigecycline-Containing Regimens for Mycobacterium abscessus Pulmonary Disease.
    Antimicrob Agents Chemother. 2022;66:e0077422.
    PubMed         Abstract available

  14. MCNEIL JC, Sommer LM, Vallejo JG, Hulten KG, et al
    Reduced Ceftaroline Susceptibility among Invasive MRSA Infections in Children: a Clinical and Genomic Investigation.
    Antimicrob Agents Chemother. 2022;66:e0074522.
    PubMed         Abstract available

  15. COX GW, Avery BP, Parmley EJ, Irwin RJ, et al
    A One Health Genomic Investigation of Gentamicin Resistance in Escherichia coli from Human and Chicken Sources in Canada, 2014 to 2017.
    Antimicrob Agents Chemother. 2022 Sep 27:e0067722. doi: 10.1128/aac.00677.
    PubMed         Abstract available

  16. MENDES RE, Hubler C, Kimbrough JH, Kantro V, et al
    In Vitro Activity of Tebipenem against Various Resistant Subsets of Escherichia coli Causing Urinary Tract Infections in the United States (2018 to 2020).
    Antimicrob Agents Chemother. 2022 Sep 28:e0121422. doi: 10.1128/aac.01214.
    PubMed         Abstract available

  17. SINGH KV, Montealegre MC, Murray BE
    Enterococcus faecium Clade Competition in the Presence of beta-Lactam Antibiotics in a Mouse GI Tract Colonization Model.
    Antimicrob Agents Chemother. 2022 Oct 18:e0090322. doi: 10.1128/aac.00903.
    PubMed         Abstract available

  18. KUNZ COYNE AJ, Alshaer M, Casapao AM, Venugopalan V, et al
    Effectiveness and Safety of Beta-Lactam Antibiotics with and without Therapeutic Drug Monitoring in Patients with Pseudomonas aeruginosa Pneumonia or Bloodstream Infection.
    Antimicrob Agents Chemother. 2022;66:e0064622.
    PubMed         Abstract available


    BMC Neurol

  19. VITHOOSAN S, Kumarasiri A, Vithanage NM, Senanayake B, et al
    Case report long segment myelitis secondary to neuro melioidosis.
    BMC Neurol. 2022;22:387.
    PubMed         Abstract available


    Clin Infect Dis

  20. KENNEDY JL, Bulitta JB, Chatham-Stephens K, Person MK, et al
    Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019.
    Clin Infect Dis. 2022;75.
    PubMed         Abstract available

  21. HONEIN MA, Hoffmaster AR
    Responding to the Threat Posed by Anthrax: Updated Evidence to Improve Preparedness.
    Clin Infect Dis. 2022;75.
    PubMed        

  22. MAXSON T, Kongphet-Tran T, Mongkolrattanothai T, Travis T, et al
    Systematic Review of In Vitro Antimicrobial Susceptibility Testing for Bacillus anthracis, 1947-2019.
    Clin Infect Dis. 2022;75.
    PubMed         Abstract available

  23. PARKER CM, Karchmer AW, Fisher MC, Muhammad KM, et al
    Safety of Antimicrobials for Postexposure Prophylaxis and Treatment of Anthrax: A Review.
    Clin Infect Dis. 2022;75.
    PubMed         Abstract available

  24. SLAY RM, Hewitt JA, Crumrine M
    Determination of the Postexposure Prophylactic Benefit of Oral Azithromycin and Clarithromycin Against Inhalation Anthrax in Cynomolgus Macaques.
    Clin Infect Dis. 2022;75.
    PubMed         Abstract available

  25. THOMPSON JM, Cook R, Person MK, Negron ME, et al
    Risk Factors for Death or Meningitis in Adults Hospitalized for Cutaneous Anthrax, 1950-2018: A Systematic Review.
    Clin Infect Dis. 2022;75.
    PubMed         Abstract available

  26. PERSON MK, Cook R, Bradley JS, Hupert N, et al
    Systematic Review of Hospital Treatment Outcomes for Naturally Acquired and Bioterrorism-Related Anthrax, 1880-2018.
    Clin Infect Dis. 2022;75.
    PubMed         Abstract available

  27. BINNEY S, Person MK, Traxler RM, Cook R, et al
    Algorithms for the Identification of Anthrax Meningitis During a Mass Casualty Event Based on a Systematic Review of Systemic Anthrax From 1880 Through 2018.
    Clin Infect Dis. 2022;75.
    PubMed         Abstract available

  28. SLAY RM, Cook R, Hendricks K, Boucher D, et al
    Pre- and Postlicensure Animal Efficacy Studies Comparing Anthrax Antitoxins.
    Clin Infect Dis. 2022;75.
    PubMed         Abstract available

  29. KUTMANOVA A, Zholdoshev S, Roguski KM, Sholpanbay Uulu M, et al
    Risk Factors for Severe Cutaneous Anthrax in a Retrospective Case Series and Use of a Clinical Algorithm to Identify Likely Meningitis and Evaluate Treatment Outcomes, Kyrgyz Republic, 2005-2012.
    Clin Infect Dis. 2022;75.
    PubMed         Abstract available

  30. LOMBARTE ESPINOSA E, Villuendas Uson MC, Arribas Garcia J, Jado Garcia I, et al
    Survival of Patient With Hemorrhagic Meningitis Associated With Inhalation Anthrax.
    Clin Infect Dis. 2022;75.
    PubMed         Abstract available

  31. CAFFES N, Hendricks K, Bradley JS, Twenhafel NA, et al
    Anthrax Meningoencephalitis and Intracranial Hemorrhage.
    Clin Infect Dis. 2022;75.
    PubMed         Abstract available

  32. HESSE EM, Godfred-Cato S, Bower WA
    Antitoxin Use in the Prevention and Treatment of Anthrax Disease: A Systematic Review.
    Clin Infect Dis. 2022;75.
    PubMed         Abstract available

  33. HENDRICKS K, Person MK, Bradley JS, Mongkolrattanothai T, et al
    Clinical Features of Patients Hospitalized for All Routes of Anthrax, 1880-2018: A Systematic Review.
    Clin Infect Dis. 2022;75.
    PubMed         Abstract available

  34. HENDRICKS K, Martines RB, Bielamowicz H, Boyer AE, et al
    Welder's Anthrax: A Tale of 2 Cases.
    Clin Infect Dis. 2022;75.
    PubMed         Abstract available

  35. DAVIS AG, Dreyer AJ, Albertyn C, Maxebengula M, et al
    Cognitive Impairment in Tuberculous Meningitis.
    Clin Infect Dis. 2022 Oct 20. pii: 6763738. doi: 10.1093.
    PubMed         Abstract available


    Curr Microbiol

  36. BEDENIC B, Pesorda L, Krilanovic M, Beader N, et al
    Evolution of Beta-Lactamases in Urinary Klebsiella pneumoniae Isolates from Croatia; from Extended-Spectrum Beta-Lactamases to Carbapenemases and Colistin Resistance.
    Curr Microbiol. 2022;79:355.
    PubMed         Abstract available

  37. MLAMBO LK, Abbasiliasi S, Tang HW, Ng ZJ, et al
    Bioactive Metabolites of Lactiplantibacillus plantarum K014 Against Methicillin-Resistant Staphylococcus aureus ATCC43300 and In Vitro Evaluation of Its Antibacterial, Antioxidant and Anti-inflammatory Activities.
    Curr Microbiol. 2022;79:359.
    PubMed         Abstract available

  38. SCOTT-BAUMANN JF, Friedersdorff JCA, Villarreal-Ramos B, King J, et al
    The Faecal Microbiome of the Wild European Badger Meles meles: A Comparison Against Other Wild Omnivorous Mammals from Across the Globe.
    Curr Microbiol. 2022;79:363.
    PubMed         Abstract available

  39. CHOUDHARY M, Shrivastava R, Vashistt J
    Acinetobacter baumannii Biofilm Formation: Association with Antimicrobial Resistance and Prolonged Survival under Desiccation.
    Curr Microbiol. 2022;79:361.
    PubMed         Abstract available

  40. SAFAI SM, Khorsandi K, Falsafi S
    Effect of Berberine and Blue LED Irradiation on Combating Biofilm of Pseudomonas aeruginosa and Staphylococcus aureus.
    Curr Microbiol. 2022;79:366.
    PubMed         Abstract available

  41. KOWALCZYK K, Wojcik-Fatla A
    Chlamydia psittaci in Faecal Samples of Feral Pigeons (Columba livia forma urbana) in Urban Areas of Lublin city, Poland.
    Curr Microbiol. 2022;79:367.
    PubMed         Abstract available


    Eur J Clin Microbiol Infect Dis

  42. PICCININI D, Bernasconi E, Di Benedetto C, Cavallo C, et al
    Ventriculo-peritoneal shunt-associated Staphylococcus schleiferi infection in an immunocompetent woman: a case report and review of the literature.
    Eur J Clin Microbiol Infect Dis. 2022 Oct 19. pii: 10.1007/s10096-022-04511.
    PubMed        


    J Bacteriol

  43. TRAUTMANN HS, Ramsey KM
    A Ribosomal Protein Homolog Governs Gene Expression and Virulence in a Bacterial Pathogen.
    J Bacteriol. 2022;204:e0026822.
    PubMed         Abstract available

  44. BESSE A, Groleau MC, Trottier M, Vincent AT, et al
    Pseudomonas aeruginosa Strains from Both Clinical and Environmental Origins Readily Adopt a Stable Small-Colony-Variant Phenotype Resulting from Single Mutations in c-di-GMP Pathways.
    J Bacteriol. 2022;204:e0018522.
    PubMed         Abstract available


    J Biol Chem

  45. DAS DK, Zafar MA, Nanda S, Singh S, et al
    Targeting dendritic cells with TLR-2 ligand-coated nanoparticles loaded with Mycobacterium tuberculosis epitope induce anti-tuberculosis immunity.
    J Biol Chem. 2022 Oct 15:102596. doi: 10.1016/j.jbc.2022.102596.
    PubMed         Abstract available


    J Clin Microbiol

  46. LUCIGNANO B, Cento V, Agosta M, Ambrogi F, et al
    Effective Rapid Diagnosis of Bacterial and Fungal Bloodstream Infections by T2 Magnetic Resonance Technology in the Pediatric Population.
    J Clin Microbiol. 2022;60:e0029222.
    PubMed         Abstract available

  47. FIDA M, Misra A, Harring JA, Kubbara A, et al
    Histoplasma capsulatum Complement Fixation and Immunodiffusion Assay Sensitivity in Culture-Confirmed Cases of Histoplasmosis: a 10-Year Retrospective Review (2011 to 2020).
    J Clin Microbiol. 2022;60:e0105722.
    PubMed         Abstract available

  48. DUNMIRE CN, Chac D, Chowdhury F, Khan AI, et al
    Vibrio cholerae Isolation from Frozen Vomitus and Stool Samples.
    J Clin Microbiol. 2022;60:e0108422.
    PubMed        

  49. DATTA K, LaRue R, Permpalung N, Das S, et al
    Development of an Interferon-Gamma Release Assay (IGRA) to Aid Diagnosis of Histoplasmosis.
    J Clin Microbiol. 2022;60:e0112822.
    PubMed         Abstract available

  50. MALDONADO-BARRUECO A, Grandioso-Vas D, Rico-Nieto A, Garcia-Rodriguez J, et al
    The Brief Case: Proteus mirabilis Causing Coraliform Lithiasis and Bacteremia in an Elderly Catheterized Patient.
    J Clin Microbiol. 2022;60:e0241321.
    PubMed        

  51. MALDONADO-BARRUECO A, Grandioso-Vas D, Rico-Nieto A, Garcia-Rodriguez J, et al
    Closing Brief Case: Proteus mirabilis Causing Coraliform Lithiasis and Bacteremia in an Elderly Catheterized Patient.
    J Clin Microbiol. 2022;60:e0241421.
    PubMed        


    N Engl J Med

  52. LEE JB, Schwartz Z
    Tinea Nigra.
    N Engl J Med. 2022;387:1501.
    PubMed        


    PLoS Negl Trop Dis

  53. OMER AT, Hasabo EA, Bashir SN, El Hag NE, et al
    Head and neck mycetoma: Clinical findings, investigations, and predictors for recurrence of the disease in Sudan: A retrospective study.
    PLoS Negl Trop Dis. 2022;16:e0010838.
    PubMed         Abstract available

  54. TOPPINO S, N'Krumah RTAS, Kone BV, Koffi DY, et al
    Skin wounds in a rural setting of Cote d'Ivoire: Population-based assessment of the burden and clinical epidemiology.
    PLoS Negl Trop Dis. 2022;16:e0010608.
    PubMed         Abstract available

  55. KWASI DA, Babalola CP, Olubiyi OO, Hoffmann J, et al
    Antibiofilm agents with therapeutic potential against enteroaggregative Escherichia coli.
    PLoS Negl Trop Dis. 2022;16:e0010809.
    PubMed         Abstract available

  56. ABDUL RAHMAN N, Rajaratnam V, Burchell GL, Peters RMH, et al
    Experiences of living with leprosy: A systematic review and qualitative evidence synthesis.
    PLoS Negl Trop Dis. 2022;16:e0010761.
    PubMed         Abstract available

  57. PARKER CT, Schiaffino F, Huynh S, Paredes Olortegui M, et al
    Shotgun metagenomics of fecal samples from children in Peru reveals frequent complex co-infections with multiple Campylobacter species.
    PLoS Negl Trop Dis. 2022;16:e0010815.
    PubMed         Abstract available


    PLoS One

  58. WARNASEKARA J, Agampodi S, Nr A
    SARIMA and ARDL models for predicting leptospirosis in Anuradhapura district Sri Lanka.
    PLoS One. 2022;17:e0275447.
    PubMed         Abstract available

  59. STREETER AJ, Rodgers LR, Masoli J, Lin NX, et al
    Real-world effectiveness of pneumococcal vaccination in older adults: Cohort study using the UK Clinical Practice Research Datalink.
    PLoS One. 2022;17:e0275642.
    PubMed         Abstract available

  60. LIAO C, Santoscoy MC, Craft J, Anderson C, et al
    Allelic variation of Escherichia coli outer membrane protein A: Impact on cell surface properties, stress tolerance and allele distribution.
    PLoS One. 2022;17:e0276046.
    PubMed         Abstract available

  61. BOLOURCHI N, Fereshteh S, Noori Goodarzi N, Badmasti F, et al
    Subtractive genomic analysis for computational identification of putative immunogenic targets against clinical Enterobacter cloacae complex.
    PLoS One. 2022;17:e0275749.
    PubMed         Abstract available

  62. AROTOLU TE, Wang H, Lv J, Shi K, et al
    Modeling the environmental suitability for Bacillus anthracis in the Qinghai Lake Basin, China.
    PLoS One. 2022;17:e0275261.
    PubMed         Abstract available

  63. KNIPPER AD, Ghoreishi N, Crease T
    Prevalence and concentration of Campylobacter in faeces of dairy cows: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0276018.
    PubMed         Abstract available

  64. DONDOV G, Amarbayasgalan D, Batsaikhan B, Badamjav T, et al
    Diagnostic performances of pepsinogens and gastrin-17 for atrophic gastritis and gastric cancer in Mongolian subjects.
    PLoS One. 2022;17:e0274938.
    PubMed         Abstract available

  65. AL-MUTAIRI NM, Ahmad S, Mokaddas E, Al-Hajoj S, et al
    First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Kuwait and evaluation of REBA MTB-MDR assay for rapid detection of MDR-TB.
    PLoS One. 2022;17:e0276487.
    PubMed         Abstract available

  66. SANTIN M, Perez-Recio S, Grijota MD, Anibarro L, et al
    Comparison of three short-course rifamycin-based regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial).
    PLoS One. 2022;17:e0276387.
    PubMed         Abstract available


    PLoS Pathog

  67. SMITH C, Lee SC
    Current treatments against mucormycosis and future directions.
    PLoS Pathog. 2022;18:e1010858.
    PubMed         Abstract available

  68. LAWRENCE AE, Berger RP, Hill DR, Huang S, et al
    Human neutrophil IL1beta directs intestinal epithelial cell extrusion during Salmonella infection.
    PLoS Pathog. 2022;18:e1010855.
    PubMed         Abstract available

  69. COHEN A, Jeng EE, Voorhies M, Symington J, et al
    Genome-scale CRISPR screening reveals that C3aR signaling is critical for rapid capture of fungi by macrophages.
    PLoS Pathog. 2022;18:e1010237.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: